Abstract:Purpose To retrospectively evaluate the safety and efficacy of percutaneous computed tomography (CT)-guided microwave ablation (MWA) in colorectal cancer (CRC) lung metastases, and to analyze prognostic factors. Materials and methods Data were collected from 31 patients with CRC lung metastases from May 2013 to September 2017. They had removed the CRC, no extrapulmonary metastases, no more than three metastases in the lung, the maximum diameter of the lesions was ≤3 cm, and all the lung metastases could be completely ablated. The ablation procedures were performed using a KY-2000 microwave multifunctional therapeutic apparatus. Efficacy is assessed two to four weeks after ablation, and follow-up are performed every three months for two years. The primary outcome was overall survival (OS). The secondary outcomes were progression-free survival (PFS), and complications. Cox regression analysis was used for the evaluation of the statistical significance of factors affecting the end result of MWA therapy. The Kaplan–Meier method was used for estimation of survival rates. Results A total of 45 metastatic lung lesions from CRC in 31 patients were treated with CT-guided MWA procedures. The median OS was 76 months. The one, two, three, and five-year survival rates were 93.5%, 80.6%, 61.3%, and 51.6%, respectively. Multivariate analysis showed that the primary tumor from the rectum ( P = 0.009) and liver metastases at the diagnosis of lung metastases ( P = 0.043) were risk factors affecting OS, while PFS was a protective factor. The median PFS was 13 months. The maximum diameter of lung metastases lesions ( P = 0.004) was a risk factor. The interval between pulmonary metastases and MWA ( P =0.031) was the protective factor. Pneumothorax was observed in 13 out of 36 procedures. Four patients developed pneumothorax requiring drainage tube insertion. No patient deaths occurred within 30 days of ablation. Three out of 31 patients (9.67%) were found to have local recurrence of the original lung metastatic ablation foci. Conclusion MWA therapy may be safely and effectively used as a therapeutic tool for the treatment of selected CRC pulmonary metastases, and the prognosis is better in patients without liver metastases at the diagnosis of lung metastases.

Local Efficacy and Survival after Microwave Ablation of Lung Tumors: A Retrospective Study in 183 Patients.

Long-term Effects of Ultrasound-Guided Microwave Ablation in the Treatment of Small Renal Cell Carcinoma

CT-guided Percutaneous Microwave Ablation of Pulmonary Malignancies: Results in 69 Cases

Microwave Ablation Vs. Surgical Resection for Treatment Naïve Hepatocellular Carcinoma Within the Milan Criteria: a Follow-Up of at Least 5 Years

Ultrasound-guided Microwave Ablation for Abdominal Wall Metastatic Tumors： A Preliminary Study

Us-Guided Percutaneous Microwave Ablation of Renal Cell Carcinoma: Intermediate-Term Results

Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results

Survival Benefits Analyses of T1a Renal Cell Carcinoma Patients Treated with Microwave Ablation

Clinical Outcome of Ultrasound-Guided Percutaneous Microwave Ablation on Colorectal Liver Metastases.

Does Primary Tumor Location Impact the Prognosis of Colorectal Liver Metastases Patients after Microwave Ablation? - Lessons from 10 Years’ Experience

[Evaluation of Long-Term Therapeutic Effects of Ultrasound-Guided Percutaneous Microwave Ablation of Liver Metastases].

Efficacy and Safety of Microwave Ablation in the Treatment of Patients with Oligometastatic Non-Small-cell Lung Cancer: a Retrospective Study.

Learning Curve of Microwave Ablation for Liver Cancers

A Study of Microwave Ablation for Small Cell Lung Cancer.

Safety and Effectiveness Analysis of Percutaneous Microwave Thermal Ablation Therapy Combined Brachytherapy for Lung Malignant Lesion

Percutaneous Microwave Ablation Versus Breast Conserving Surgery for 2-5Cm Breast Cancer: A Two-Center, Retrospective Study

Microwave ablation without subsequent lumpectomy versus breast-conserving surgery for early breast cancer: a propensity score matching study

Evaluating the Efficacy and Safety of Ultrasound-Guided Percutaneous Microwave Ablation for the Treatment of Adrenal Metastasis

Local Tumor Progression After Ultrasound-Guided Percutaneous Microwave Ablation Of Stage T1a Renal Cell Carcinoma: Risk Factors Analysis Of 171 Tumors

Long-term outcome following microwave ablation of lung metastases from colorectal cancer

Analysis of clinical curative effect of microwave ablation in lung cancer